Home› Funds› UTI FTIF Series XXVIII-XIV (1147 Days) - Direct Pl

UTI FTIF Series XXVIII-XIV (1147 Days) - Direct Plan - Growth OptionI

UTI · Equity Fund
High
₹12.56
Current NAV
10 May 2021
5.5%
1Y Return
7.9%
3Y CAGR
11.3%
5Y CAGR
Watchlist
NAV History (1 Year)
Analysis & Suitability
Pros / Upsides
  • Highly cost-efficient with a low expense ratio of 0.93%.
  • Excellent risk-adjusted performance (Sharpe Ratio: 1.93).
  • Generates significant excess returns relative to benchmark index (Alpha: 2.43).
  • Very large asset base (AUM: ₹16,980 Cr) indicating high investor trust and liquidity.
Cons / Risks
  • Subject to high equity market volatility and short-term capital fluctuations.
  • Sluggish 3-year performance, lagging behind primary equity benchmarks.
Suitable for
  • Long-term wealth creation (5+ years horizon) like retirement or child education.
  • Systematic investments (SIP) for long-term target goal-based planning.
Not suitable for
  • Short-term goals (under 3 years) where preserving the capital is the main priority.
  • Short-term trading or speculative investment horizons.
Risk Profile: High Risk
Low Moderate High Very High
Risk Metrics
1.93
Sharpe Ratio
0.63
Beta
2.43
Alpha
2.57
Sortino
Fund Details
Fund House UTI
Category Equity Fund
AUM ₹16980 Cr
Expense Ratio 0.93%
Min SIP ₹500
Min Lumpsum ₹1000
SIP Calculator Compare Funds
Similar Funds in Equity Fund
UTI Regular Saving Fund ( Segregated - 17022020) - Direct Plan - Flexi IDCW
UTI
₹3.41 339.0%
UTI - Regular Saving Fund (Segregated - 17022020) - Direct Plan - Monthly Payment Option
UTI
₹4.01 339.0%
UTI Regular Saving Fund ( Segregated - 17022020) - Direct Plan - Monthly IDCW
UTI
₹1.45 339.0%
UTI - Regular Saving Fund (Segregated - 17022020) - Direct Plan - Growth Option
UTI
₹4.08 339.0%